Connection

Laurent Peyrin-Biroulet to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Laurent Peyrin-Biroulet has written about Cost-Benefit Analysis.
Laurent Peyrin-Biroulet
Connection Strength
0.138
Cost-Benefit Analysis
  1. Big data in IBD: a look into the future. Nat Rev Gastroenterol Hepatol. 2019 05; 16(5):312-321.
    View in: PubMed
    Score: 0.094
  2. Biosimilars for the Management of Inflammatory Bowel Diseases: Economic Considerations. Curr Med Chem. 2019; 26(2):259-269.
    View in: PubMed
    Score: 0.023
  3. Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe. Expert Rev Pharmacoecon Outcomes Res. 2017 Dec; 17(6):597-606.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.